View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Ropack
15 January 2012

Recent Milestones Mark Ropack’s 35th Anniversary and Position the Contract Packager for Growth

During its 35th anniversary, Ropack celebrates its notable past which continues to shape the company. At the same time, it demonstrates that it is a company clearly focused on the future. Two recent milestones propel the contract packager for the pharmaceutical and consumer healthcare industries into that strong future: the launch of a $9m low RH, controlled-temperature production facility for stick-pack and all temperature- and humidity-sensitive products and the acquisition of a neighboring building which expands the company’s campus.

In 1976, Roger Massicotte and a partner recognized a niche opportunity: the production of private label sugar pouches requiring short runs that the large refineries would not accommodate. So, in 4,000 square feet of rented space, the two founders – Ropack’s only staff for more than a year – produced 300 different brands on a pair of secondhand machines skillfully refurbished by Massicotte. Today, Ropack provides primary and secondary packaging, warehousing and distribution to some of the most respected brands in the pharmaceutical and consumer healthcare industries. Owning 247,000 square feet of space, with green fields that can accommodate another 60,000 square feet, the company employs 300 people.

"My father started Ropack in 1976 with a passion to make it successful," says Yves Massicotte, the company’s president and CEO. "That determination motivates me every day and is an integral part of our company culture. Our newest production facility is the work of our terrific team, each of them driven to ensure that Ropack’s facilities, equipment, quality, integrity and service cannot be matched elsewhere in North America."

The new 15,000-square-foot temperature- and humidity-controlled facility, which began production in May, increases the company’s packaging options to include stick-pack – slim, tube-shaped packets – and reflects Ropack’s commitment to spearhead in North America this packaging option which is a preferred choice in Europe and Asia. "As a company anchored by long-term strategy, it’s particularly appropriate that we are launching this state-of-the-industry facility during our 35th anniversary," observes Massicotte.

Long-term vision also drove the decision to purchase the neighboring 37,000-square-foot building, earmarked to accommodate the demand for warehousing and distribution, and eventually to increase production and office space. "Expanding our square footage signals our commitment to growth and to ongoing improvements that place Ropack at the forefront of technology and service," notes Massicotte. "It tells our clients, both current and prospective, of our stability as well as our ability to be an effective production extension of their own company."

Ropack's Paul Dupont explains how growing trends in the consumer healthcare industry signal promising market opportunities for leading nutraceutical and pharmaceutical companies.
Stickpack packaging in single-dose is globally accepted for its accuracy, convenience and cost savings.
Blister packaging, not long ago considered a less significant segment of the North American pharmaceutical packaging industry, is now outpacing most other industry segments.
The expanding global pharmaceutical industry projects a 4%-6% annual growth and forecasts that it will reach a value of $1 trillion by 2014.
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU